期刊文献+

LPSP霜剂在烧伤创面的应用 被引量:3

THE APPLICATION OF LPSP CREAM IN THE BURNT SKIN
暂未订购
导出
摘要 目的 :论证 L PSP霜剂对烧伤浅创面的治疗效果。方法 :采用 L PSP霜剂为治疗组 (A组 ) ,分别与不含 L PSP成分的对照组 (B组 ) .1%磺胺嘧啶银冷霜比较治疗组 (C组 )进行观察比较。结果 :A组与 B组比较 ,前组创面愈合时间缩短 ,有抑菌能力 ;A组与 C组比较 ,前者对创面刺激轻、镇痛 ,创面愈合后色素沉着较轻 ,质地柔软。结论 :L PSP霜剂对烧伤创面刺激少、镇痛 ,有抑菌能力 ,有促进创面愈合及减轻色素沉着的优点。 Objective:To conform the effects of LPSP cream in burnt superficial Method:We divided patients into three groups:A is the treating group with LPSP cream B is the control C Group is comparative treating group with 1% SD Ag cream Results:Compared with Groups B and C, the patients in Group A recovered fast,have less bacteria infection and less pigmentation in burnt skin Conclusion:The character of LPSP cream are less irritation,analgesia,produce less pigmentation and promote recovery
出处 《广西医科大学学报》 CAS 2000年第1期16-17,共2页 Journal of Guangxi Medical University
基金 广西卫生厅资助课题!(9702 )
关键词 LPSP霜剂 磺胺嘧啶银冷霜 烧伤 浅创面 LPSP cream SD Agcream burnt superficial area
  • 相关文献

参考文献15

二级参考文献96

共引文献152

同被引文献38

  • 1金生,张大志,陈压西.Toll样受体研究进展与临床免疫[J].重庆医学,2004,33(9):1423-1426. 被引量:3
  • 2俞永新.国内外狂犬病疫苗的发展和现状[J].上海预防医学,2006,18(5):216-218. 被引量:28
  • 3王健,冷静,王启辉.LPSp辅佐HBsAg诱导机体产生特异性抗体的机制[J].细胞与分子免疫学杂志,2007,23(6):559-561. 被引量:6
  • 4de Gregorio E., Tritto E., and Rappuoli R., 2008, Alum adjuvanticity: Unraveling a century old mystery, Eur. J. Immunol., 38(8): 2068-2071.
  • 5Evans J.T., Cluff C.W., Johnson D.A., Lacy M.J., Persing D.H., and Baldridge J.R., 2003, Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529, Expert Rev.Vaccines, 2(2): 219-229.
  • 6Galanos C., Ltideritz O., Rietschel E.T., Westphal O., Brade H., Brade L., Freudenberg M., Schade U., Imoto M., Yoshimura H., Kusumoto S., and Shiba T., 1985, Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities, Eur. J. Biochem., 148(1): 1-5.
  • 7Garcon N., Chomez P., and van Mechelen M., 2007, Glaxo-SmithKline adjuvant systems in vaccines: Concepts, achievements and perspectives, Expert Rev. Vaccines, 6(5): 723-739.
  • 8Goto S., Sakai S., Kera J., Suma Y., Soma G.I., and Takeuchi S., 1996, Intradermal administration of lipopolysaccharide in treatment of human cancer, Cancer Immunol Immunother, 42(4): 255-261.
  • 9Granucci F., Ferrero E., Foti M., Aggujaro D., Vettoretto K., and Ricciardi-Castagnoli P., 1999, Early events in dendritic cell maturation induced by LPS, Microbes Infect, 1 (13): 1079-1084.
  • 10Iwamoto I., Goto S., Kera J., Soma G.I., Takeuchi S., and Nagata Y., 1996, Mechanistic analysis of high antitumor effect of intradermal administration of lipopolysaccharide from Pantoea Agglomerans, Med. Oncol., 13(2): 103-109.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部